Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: bevacizumab|BIOLOGICAL: trastuzumab|DRUG: carboplatin|DRUG: docetaxel|OTHER: laboratory biomarker analysis
Sponsor: Case Comprehensive Cancer Center